Summary
Cardinal Health Inc. (CAH) reported strong revenue growth of 11% for the third quarter ended September 30, 2006, reaching $21.4 billion, up from $19.2 billion in the prior year's quarter. This growth was primarily driven by the Healthcare Supply Chain Services – Pharmaceutical segment, which accounts for the majority of revenue. Operating earnings also saw a significant increase of 23% to $463.7 million, reflecting improved operational efficiency and the positive impact of reduced equity-based compensation expenses. The company is navigating several complex legal and regulatory matters, including ongoing SEC and U.S. Attorney investigations, shareholder litigation, and an FDA Class 1 recall of its Alaris SE pump. While these issues present potential risks and require significant management attention, the company has taken steps to address them, including reserving for potential settlements and incurring charges related to the pump recall. Despite these challenges, Cardinal Health demonstrated a solid financial performance in the quarter, with net earnings increasing by 19% to $270.7 million.
Key Highlights
- 1Revenue increased by 11% to $21.4 billion, driven by strong performance in the Healthcare Supply Chain Services – Pharmaceutical segment.
- 2Operating earnings grew by 23% to $463.7 million, indicating improved profitability.
- 3Net earnings rose by 19% to $270.7 million, reflecting overall business strength.
- 4The company repurchased approximately $445.3 million of its Common Shares during the quarter as part of a $2 billion share repurchase program.
- 5A $13.5 million charge was recorded related to the Alaris SE pump recall, which was classified as a Class 1 recall by the FDA.
- 6The company reached an agreement-in-principle with the SEC staff for a potential settlement, which would include a $35 million penalty.
- 7Effective tax rate improved to 27.8% from 31.3% due to adjustments to tax reserves.